Biotech | May 06, 2022
Procter & Gamble Health posts 14 per cent growth in net profit in Q3
The increase in PAT is driven by higher sales and lower marketing and depreciation charge vs the same period last year
The increase in PAT is driven by higher sales and lower marketing and depreciation charge vs the same period last year
The plant is expected to start commercial operations from Q4FY24
The funding round is led by Kalaari Capital. Aflac Ventures, Digital Horizon, Stride Ventures, and existing investors also participated in the round
Casper Pharma is a Hyderabad based SEZ company engaged in the formulations business. Post-purchase of shares, the target entity would become a wholly-owned subsidiary of SPL
The amalgamation will integrate business operations and provide impetus to the existing portfolio of Alembic
Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments
Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025
The company already has the world’s largest capacity for ibuprofen and is now looking at expansion in new molecules as the idea is to actually de-risk the business
Ten new Ayush hospitals and one Ayurvedic college will be set up in Nagaland and Mizoram
Company has bought 7.73 million shares for KRW 146.1 billion thus securing the largest shareholder status in Bukwang Pharmaceutical
Subscribe To Our Newsletter & Stay Updated
